Dilia Giuggioli

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Maria Rosa Pellico

Istituto Ortopedico Gaetano Pini

ITALY

View details

ENRICO FUSARO

Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino

ITALY

View details

Alessia Alunno

ITALY

View details

Alarico Ariani

ITALY

View details

Michael Hughes

The University of Manchester

UNITED KINGDOM

View details

Francesco Gherardini

Associate Professor, Ph.D.

University of Modena and Reggio Emilia

ITALY

View details

Marino Paroli

Sapienza University of Rome

ITALY

View details

Christopher Denton

University College London

UNITED KINGDOM

View details

Francesca Ingegnoli

Università degli Studi di Torino

ITALY

View details

Corrado Campochiaro

Vita-Salute San Raffaele University

ITALY

View details

Ottavio Secchi

Lecturer

Università degli Studi di Cassino e del Lazio Meridionale

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dilia Giuggioli

Research Interests

Explore related searches

Contact this professor

Articles (21)

Treatment recommendations for the systemic pharmacological treatment of systemic sclerosis digital ulcers: Results from the World Scleroderma Foundation Ad Hoc Committee

Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry.

Prevalence of sacroiliitis on magnetic resonance enterography in Crohn's disease and its association with intestinal findings: a monocentric observational cross-sectional study.

First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry.

Menopause in systemic sclerosis: the impact on clinical presentation in a multicenter cross-sectional analysis from the National Registry of the Italian Society for Rheumatology (SPRING-SIR).

Long-term effects of selexipag in systemic sclerosis-associated digital ulcers: a case control multicentre observational study.

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.

Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology.

Recommendations for the local management of digital ulcers in systemic sclerosis: A report from the World Scleroderma Foundation (WSF) 'Ad hoc committee'.

Role of COVID-19 in the Progression of Scleroderma Interstitial Lung Disease and New Onset Pulmonary Hypertension: A Challenging Case Report.

Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry

Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group

Rituximab retention rate in systemic sclerosis: a long term real-life multicenter study.

Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study

Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review

One‐year clinical experience on the use of Nintedanib in systemic sclerosis

Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase.

Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review.

Surgical management of digital ulcers in systemic sclerosis: A systematic literature review.

Real life use of prostacyclin analog (iloprost), a multi-centric survey data from the Scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature.

Collaborators (11)

Maria Rosa Pellico

ENRICO FUSARO

Alessia Alunno

Alarico Ariani

Michael Hughes

Francesco Gherardini

Marino Paroli

Christopher Denton

Francesca Ingegnoli

Corrado Campochiaro

Ottavio Secchi

Make your next move.